Preclinical Studies

TORONTO, ONTARIO — (Marketwired) — 10/19/17 — Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs in the medical cannabis and cannabinoid pharmaceuticals sectors, today announced its results for the fiscal year ended June 30, 2017. […]

by

Civil Air Patrol members from around the state participated in a multi-day training exercise this past weekend, beginning The Pierce County Airport-Thun Field (PLU) in Puyallup, WA, served as the mission base, while five remote staging areas were activated across the state including Yakima, Spokane, Walla Walla, Bellingham, and Vancouver. According to Colonel James Furlong, […]

by

Treatment with cannabidiol reduces some major symptoms in mice with a genetic condition recapitulating Dravet syndrome, a devastating childhood brain disorder. Cannabidiol is a non-intoxicating substance among the several active compounds derived from Cannabis plants. This molecule can also be produced synthetically. The results of its use to treat Dravet syndrome are reported in the […]

by

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, Canada. The company estimates that 45–90% of adults with advanced COPD suffer […]

by

Brazilian doctors have begun prescribing HempMeds Brasil‘s hemp cannabis oil to ALS and psoriasis patients, the company’s U.S. parent reports. San Diego-based Medical Marijuana said it is the first time Brazilian physicians have prescribed the product, known as Real Scientific Hemp Oil, to those with the two diseases. HempMeds Brasil has been providing medical cannabis to patients for […]

by

Posted in: Medical Procedure News | Medical Science News | Medical Research News | Medical Condition News Tags: Blood, Brain, Cell, Child Health, Children, Clinical Trial, CRISPR, DNA, Drugs, Duchenne Muscular Dystrophy, Dystrophin, Education, Exon, Eye, Gene, Gene Therapy, Genetic, Genetic Disorder, Genome, G-Protein, Hospital, Immune System, Laboratory, Liver, Muscle, Muscular Dystrophy, Mutation, Neuromuscular Disease, […]

by

When HIV attacks a T cell, it attaches itself to the cell’s surface and launches a “harpoon” to create an opening to enter and infect the cells. To stop the invasion, researchers from the Penn Center for AIDS Research at the University of Pennsylvania and scientists from Sangamo BioSciences, Inc. have developed genetically engineered T […]

by

A dried flower bud of the Cannabis plant. Credit: Public Domain Robert MacCoun, a professor of law and a senior fellow at the Freeman Spogli Institute for International Studies, relays the potential risks and benefits of legalizing marijuana. His research focuses on drug policy, and he has written extensively about the effects of marijuana from […]

by

Many cannabis consumers have experienced the infamous red eye. The eyes are often the most common giveaway after a serious session with a vaporizer. But how does cannabis affect overall eye health? Yet, while some may find the herb’s visible effects on the eyes to be burdensome, there are several surprising ways that cannabis supports […]

by

Shares of PreveCeutical Medical Inc. are expected to begin trading on the Canadian Securities Exchange on July 14 under the symbol PREV. The company, named after its focus on preventative nutraceuticals, has a pipeline that includes a cannabidiol-infused soluble gel delivery system and a dual-gene therapy targeting obesity and diabetics. In April, PreveCeutical formed a […]

by

Growing medical cannabis. Credit: Tilray Although cannabis had been used for many centuries for treatment of seizure disorders, medical use became prohibited in the 20th century. However, with the loosening of laws regarding medical marijuana, research and clinical use of marijuana-derived substances are increasing. This has prompted the editors of Epilepsy Behavior to produce a […]

by